News

December 29, 2016

Join Us for an Upcoming Webcast about SPINRAZA TM (nusinersen)

Please join Cure SMA, MDA and representatives from Biogen to learn more about SPINRAZA™ (nusinersen). As you know, SPINRAZA recently received FDA approval in the U.S. for the treatment of Spinal Muscular Atrophy (SMA) in pediatric and adult patients. In order to receive an update on SPINRAZA, please join this webcast, which is intended...

READ MORE   |  

Topics: Community & Awareness, Clinical Trials, Advocacy, Front Page News

December 23, 2016

Biogen Provides Community Statement and Q&A on the Approval of Spinraza for SMA

Biogen provided the following statement on the approval of Spinraza for SMA:

Dear Members of the SMA Community,

Today, the SMA community achieved a goal that would not have been possible without the support and dedication of the families, physicians and researchers who have passionately pursued a treatment for Spinal Muscular...

READ MORE   |  

Topics: Community & Awareness, Clinical Trials, Front Page News

December 23, 2016

Ionis Pharmaceuticals Issues Community Statement on the Approval of Spinraza

Ionis Pharmaceuticals has issued the following community statement on the approval of Spinraza for SMA:

Dear Members of the SMA Community,

Today is a historic day for the SMA community with the approval of SPINRAZA™ (nusinersen) by the U.S. Food and Drug Administration (FDA) for the treatment of Spinal Muscular Atrophy (SMA). ...

READ MORE   |  

Topics: Community & Awareness, Clinical Trials, Front Page News

Items 22 - 24 of 320  Previous12345678910Next

© 2014 Cure SMA | Privacy Policy

Powered by Blackbaud
nonprofit software